| 查看: 2381 | 回复: 8 | ||||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||||
[交流]
关于Biomaterials投稿
|
||||
|
第一次投Biomaterials,有好多问题不是太懂,谁投过给些建议。 1.实验数据是不是放在文章的最后面 2.A template for the covering letter is found on the Biomaterials website.我没找到,想问一下你们在哪找到的 |
» 猜你喜欢
2026年的国家社科基金项目通讯评审的新规则与新动向、新挑战
已经有7人回复
今天基金会出结果吗?20260819
已经有18人回复
我面上完蛋了
已经有14人回复
范进中举一文的中心思想
已经有8人回复
只有每年这种时候来逛逛小木虫
已经有27人回复
明天应该可查了!?
已经有5人回复
如果此刻你正在为国基感到焦虑,不妨来听听这首《基金之外》
已经有7人回复
没有任何消息-是不是就凉了
已经有8人回复
人气不行了
已经有10人回复
能否退出参与的面上项目解除限项
已经有24人回复
» 本主题相关价值贴推荐,对您同样有帮助:
关于一篇文献的题目
已经有5人回复
2012 SCI impact factor 生物材料类 评点
已经有9人回复
论文投稿刊物选择
已经有1人回复
» 抢金币啦!回帖就可以得到:
告别流水线爽文!108万字完结仙侠《女娲石之灵石奇缘(仙界篇)》值得细品
+1/5026
2026年工程管理与智慧城市国际会议 (EMSC 2026)
+1/694
真诚征友
+1/189
基金祈福
+1/154
散金币
+1/121
上海交通大学张航课题组招聘博士后(电化学能量存储与转换)
+1/99
上海交通大学张航课题组招聘博士后(电化学储能)
+1/87
武汉,诚征男友,不异地,年龄大了
+1/40
祈福基金得中,科研生涯顺利圆满
+1/28
基金放榜前
+1/12
2027年博士申请
+1/10
【交叉科研合作】诚邀多学科教授、博士共建学生实践课题库
+1/7
厦大化院海优团队招收2027级【博士】和【推免硕士】研究生各2名
+1/6
南京大学 智能驱动与感知材料实验室 诚招申请考核博士生/科研助理/博士后
+1/4
中科院大连化学物理研究所 招聘 催化剂研发方向 科研助理 2名
+1/4
出全新蔡司 Plan?APOCHROMAT 20×/0.8 平场复消色差物镜
+1/2
【科研项目征集】一项可在 4—8 周完成的小任务,也值得被认真对待
+1/2
新审查指南施行半年,AI方向的专利申请是不是更看"技术味"了?
+1/2
南方医科大学深圳医院陈烨/余涛教授课题组联合培养博士后招聘
+1/2
单细胞测序样本制备与质控运输全流程指南
+1/2
7楼2013-04-23 08:50:25
nono2009
超级版主 (文学泰斗)
-

专家经验: +21105 - SEPI: 10
- 应助: 28684 (院士)
- 贵宾: 513.911
- 金币: 2555230
- 帖子: 1602255
- 在线: 65200.9小时
- 虫号: 827383
★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
|
楼主是看的这里吗:http://www.elsevier.com/journals ... 2/guide-for-authors 这么没有查到你说的A template for the covering letter is found on the Biomaterials website |
2楼2012-11-17 19:30:02
3楼2012-11-17 22:01:53
★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
|
亲,你可以在EES的主页上的右边栏上点Author declaration,然后就会直接下载一个word版本的author declaration,而 A template for the covering letter will be found at the end of this document:顺便给你复制了一个,因为好还不会用附件啊 We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. [CAN BE DELETED IF NOT RELEVANT] We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. [OR] We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. [CAN BE DELETED IF NOT RELEVANT] We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from biomaterials@online.be. Signed by all authors as follows: [LIST AUTHORS AND DATED SIGNATURES ALONGSIDE] |
4楼2012-11-17 22:38:10









回复此楼